The DOI matches its Crossref record; 137 of the 137 references it cites were found in a registry or an index.
Glucose metabolism in the amygdala in depression: Relationship to diagnostic subtype and plasma cortisol levels
Abstract
In a previous positron emission tomography (PET) study of major depression, we demonstrated that cerebral blood flow was increased in the left amygdala in unipolar depressives with familial pure depressive disease (FPDD) relative to healthy controls [J. Neurosci. 12 (1992) 3628.]. These measures were obtained from relatively low-resolution PET images using a stereotaxic method based upon skull X-ray landmarks. The current experiments aimed to replicate and extend these results using higher-resolution glucose metabolism images and magnetic resonance imaging (MRI)-based region-of-interest (ROI) analysis. The specificity of this finding to FPDD was also investigated by assessing depressed samples with bipolar disorder (BD-D) and depression spectrum disease (DSD). Finally, the relationship between amygdala metabolism and plasma cortisol levels obtained during the scanning procedure was assessed. Glucose metabolism was measured using PET and 18F-fluorodeoxyglucose (18FDG) in healthy control (n=12), FPDD (n=12), DSD (n=9) and BD-D (n=7) samples in the amygdala and the adjacent hippocampus. The left amygdala metabolism differed across groups (P<.001), being increased in both the FPDD and BD-D groups relative to the control group. The left amygdala metabolism was positively correlated with stressed plasma cortisol levels in both the unipolar (r=.69; P<.005) and the bipolar depressives (r=0.68;.1<P<.05). In contrast, neither significant main effects of diagnosis nor significant relationships with plasma cortisol were evident in post hoc analyses of metabolism in the right amygdala or the hippocampus. Preliminary assessment of BD subjects imaged during remission suggested that amygdala metabolism is also elevated in remitted subjects who are not taking mood-stabilizing drugs, but within the normal range in subjects taking mood stabilizers. These data confirm our previous finding that neurophysiological activity is abnormally increased in FPDD, and extend it to BD-D. These abnormalities were not accounted for by spilling in of radioactivity from the adjacent hippocampus. The correlation between left amygdala metabolism and stressed plasma cortisol levels may conceivably reflect either the effect of amygdala activity on corticotropin-releasing hormone (CRH) secretion or the effect of cortisol on amygdala function.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Notably, the depressive subgroups (eg, BD FPDD) that show reductions in regional gray matter volume also show evidence of having elevated glutamatergic transmission and cortisol secretion (Drevets et al, 2002b).”
From Neurocircuitry of Mood Disorders (2010) · cites this paper as Drevets et al, 2002b
In the citing paper
“Depressed subjects also show exaggerated cortisol responses to stress (Drevets et al, 1999(Drevets et al, , 2002b) )”
From Neurocircuitry of Mood Disorders (2010) · cites this paper as Drevets et al, 2002b
In the citing paper
“Subjects with FPDD or familial BD also show elevations of glucose metabolism, which largely reflects glutamate transmission (see below), in the medial and orbital PFC, amygdala, ventral striatum, and cingulate cortex regions that show reductions in gray matter volume and cellular elements.”
From Brain structural and functional abnormalities in mood disorders: implications for neurocircuitry models of depression (2008) · cites this paper as Drevets et al. 2002b
In the citing paper
“Excessive amygdala activity combined with reduced ventral ACC gray matter thus conceivably may contribute to the excessive cortisol response to stress seen in depressed humans (Drevets et al. 2002b; McEwen and Magarinos 2001; Gold et al. 2002).”
From Brain structural and functional abnormalities in mood disorders: implications for neurocircuitry models of depression (2008) · cites this paper as Drevets et al. 2002b
In the citing paper
“Following the evidence regarding the impact of natural and built environments on physical health, there are emerging data suggesting the relevance of biophysical factors such as air pollution, persistent organic and heavy metal pollutants, 285 and ambient noise in terms of increasing the risk for developing depression. 286”
From Time for united action on depression: a Lancet–World Psychiatric Association Commission (2022) · cites this paper as [285]
3 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Hamilton, M. (1960) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.23.1.56 · Cited by 32,817
(1970) · Cited by 24,983
Diagnostic and Statistical Manual of Mental Disorders (DSM-IV)
Hu, R. J. (2003) · Encyclopedia of the Neurological Sciences · doi:10.1016/b0-12-226870-9/01070-4 · Cited by 9,117
A Rating Scale for Mania: Reliability, Validity and Sensitivity
Young, R. C., Biggs, J. T., Ziegler, V. E., & Meyer, D. A. (1978) · British Journal of Psychiatry · doi:10.1192/bjp.133.5.429 · Cited by 8,744
(2005) · Choice Reviews Online · doi:10.5860/choice.43-0626 · Cited by 4,674
Psychopharmacology: The Fourth Generation of Progress
Bloom, F. E., & Kupfer, D. J. (1995) · Medical Entomology and Zoology · Cited by 2,985
Subgenual prefrontal cortex abnormalities in mood disorders
Drevets, W. C., Price, J. L., Simpson, J. R., Todd, R. D., Reich, T., Vannier, M., & Raichle, M. E. (1997) · Nature · doi:10.1038/386824a0 · Cited by 2,693
Self-citationOngur, D. (2000) · Cerebral Cortex · doi:10.1093/cercor/10.3.206 · Cited by 2,627
Phelps, M. E., Huang, S. C., Hoffman, E. J., Selin, C., Sokoloff, L., & Kuhl, D. E. (1979) · Annals of Neurology · doi:10.1002/ana.410060502 · Cited by 2,418
Adolphs, R., Tranel, D., Damasio, H., & Damasio, A. (1994) · Nature · doi:10.1038/372669a0 · Cited by 2,360
Research works printed but not linked: 11
- Ball, 1998, Control state stability for PET brain imaging: “eye-closed rest,” same day versus separate day, Neurology, 38, 363
- Bowley, 2000, Glial changes in the amygdala and entorhinal cortex in mood disorders, Soc Neurosci Abstr, 26, 86710
- Drevets, 1996, State-and trait-like neuroimaging abnormalities in depression: effects of antidepressant treatment, Soc Neurosci Abstr, 22, 266
- Drevets, 2001, Abnormal hemodynamic responses to facially expressed emotion in major depression, Soc Neurosci Abstr, 27
- Drevets, 1995, Functional anatomical differences between major depressive subtypes, J Cerebral Blood Flow and Metab, 15, S93
- Gotthardt, 1995, Cortisol, ACTH, and cardiovascular response to a cognitive paradigm in aging and depression, Am J Physiol, 268, R865
- Kalin, 2001, Venlafaxine induces early and late changes in the neural circuitry of emotion that correlate with treatment response, Biol Psychiatry, 49, 92S
- Kegeles, 1999, Response of cortical metabolic deficits to serotonergic challenges in mood disorders, Biol Psychiatry, 45, 76S
- Mentis, 1995, Cerebral glucose metabolism in late onset depression without cognitive impairment, Neurosci Abstr, 21, 1736
- Ordway, 1991, Preferential reduction of binding of 125(super)I-iodopindolol to beta-l adrenoceptors in the amydala of rats after antidepressant treatments, J Pharmacol Exp Ther, 257, 68l
- Rosoklija, 2000, vol. 57, 349
Cited by
Molecular Mechanisms of Depression: Perspectives on New Treatment Strategies
Lang, U. E., & Borgwardt, S. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350094 · Cited by 8,475
Drevets, W. C., Price, J. L., & Furey, M. L. (2008) · Brain Structure and Function · doi:10.1007/s00429-008-0189-x · Cited by 2,241
“…antidepressant therapies may compensate for this dysfunction by modulating the pathological limbic activity which putatively mediates depressive symptoms (Drevets et al. 2002a) and the expression of neurotrophic/ neuroprotective factors that preserve the function of the MPFC (Manji et al. 2001).”
BackgroundInfluentialSelf-citationPezawas, L., Meyer-Lindenberg, A., Drabant, E. M., Verchinski, B. A., Munoz, K. E., Kolachana, B. S., Egan, M. F., Mattay, V. S., Hariri, A. R., & Weinberger, D. R. (2005) · Nature Neuroscience · doi:10.1038/nn1463 · Cited by 1,980
Neurocircuitry of Mood Disorders
Price, J. L., & Drevets, W. C. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2009.104 · Cited by 1,606
Self-citationThe neurobiological consequences of early stress and childhood maltreatment
Teicher, M. H., Andersen, S. L., Polcari, A., Anderson, C. M., Navalta, C. P., & Kim, D. M. (2003) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(03)00007-1 · Cited by 1,465
Metadata
- Authors
- Drevets, W. C., Price, J. L., Bardgett, M. E., Reich, T., Todd, R. D., & Raichle, M. E.
- Affiliations
- National Institutes of Health (US)
- Washington University in St. Louis (US)
- Corresponding author
- Drevets, Wayne C
- Venue
- Pharmacology Biochemistry and Behavior
- Publisher
- Elsevier BV
- Published
- 2002-03
- Volume
- 71
- Issue
- 3
- Pages
- 431-447
- ISSN
- 0091-3057 (ISSN-L)
- OpenAlex
- W2011140471
- Cited by
- 457
- References
- 137
- Citations by year
- 2026: 2 · 2025: 10 · 2024: 8 · 2023: 9 · 2022: 6 · 2021: 31 · 2020: 11 · 2019: 10 · 2018: 15 · 2017: 12 · 2016: 12 · 2015: 12 · 2014: 20 · 2013: 23 · 2012: 29
- FWCI
- 10.89
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- Locations
- Pharmacology Biochemistry and Behavior (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Dana Foundation
- National Institutes of Health (5r29mh051137-04, 1k20mh000928-01)
- National Institute of Mental Health (MH-00928, MH01109, MH51137)
- Topics
- Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Keywords
- major depressive disorder, bipolar disorder, plasma cortisol, hippocampus, 18F-FDG PET, region of interest analysis, corticotropin-releasing factor, mood stabilizers
- MeSH terms
- Adolescent, Adult, Amygdala, Major Depressive Disorder, Female, Glucose, Humans, Hydrocortisone, Male, Middle Aged, Linear Models
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Glucose metabolism in the amygdala in depression: Relationship to diagnostic subtype and plasma cortisol levels. https://app.cochat.ai/papers/10.1016/s0091-3057(01)00687-6
- The paper
- Drevets, W. C., Price, J. L., Bardgett, M. E., Reich, T., Todd, R. D., & Raichle, M. E. (2002). Glucose metabolism in the amygdala in depression: Relationship to diagnostic subtype and plasma cortisol levels. Pharmacology Biochemistry and Behavior. https://doi.org/10.1016/s0091-3057(01)00687-6
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.